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NEUROHUMORS AND OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES IN
CEREBROSPINAL FLUID: A REVIEW OF THE LITERATURE**
There has been a considerable resurgence of interest in recent years in anal-
ysis of cerebrospinal fluid in neurological and psychiatric disorders. Four
monographs and a review article have summarized much of the pertinent
literature."' '5'° The purpose of this review is to call attention to an area
that has not been adequately described in the publications referred to above.
It will comprehensively summarize the literature since 1910 dealing with
neurohumors and other pharmacologically active substances in cerebro-
spinal fluid. An attempt will be made to organize in a critical manner
some of this material, and to discuss further avenues of investigation.
INTRODUCTION
Neurohumors may be defined as highly active, naturally-occurring sub-
stances involved in neuronal activity, that are found in the nervous system
in such minute concentrations, as to generally require bioassay techniques
for their determination. (Spectrophotofluorimetric methods have also been
used for this purpose in recent years). Substances usually considered as
neurohumors are listed as follows:
1. Acetylcholine a quarternary ammonium compound
2. Biogenic amines-
a. catecholamines
(i) noradrenaline
(ii) adrenaline
b. 5-Hydroxytryptamine (serotonin)
c. Histamine
Substance P (a polypeptide) and dopamine (a catecholamine) have also
been considered as potential neurohumors, but have never been reported
in cerebrospinal fluid. The same is true of gamma-aminobutyric acid
(GABA), although the peculiarly high concentrations of this substance
found in brain would make GABA an exception to the rule that neuro-
humors are found in minute amounts in nervous tissue.
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Giarmane and Crossland17 have recently published reviews of current
concepts of the neurophysiological significance of these substances found in
brain. Briefly, it may be stated that neurohumors are thought to play a role
in transmission of the nerve impulse, both in the peripheral and central
nervous systems. This role may be that of direct synaptic transmission of
the impulse to the subsynaptic membrane, as is probable with acetylcho-
line, or it may be that of a 'neuroregulatory' agent modulating neural func-
tion in some, as yet unknown, manner. This latter concept has been de-
veloped as a result of the accumulation of a large body of data on amines
that refuses to fall into any simple scheme and yet makes it apparent that
many of these substances are intimately involved in neuronal activity.
The problem of interpretation of data resulting from analysis of brain
homogenates, as applied to the physiology of the living brain, has always
been the subject of much concern to workers in this field. Acetylcholine,
the neurohumor most intensively studied, is a highly labile substance prone
to rapid enzymatic and nonenzymatic destruction when in the free form.
Furthermore, study of these substances in human beings usually precludes
direct analysis of the brain. For these reasons, attention has been directed
to CSF as a potential source of information in living animals. The funda-
mental assumption upon which such studies are based is that neurohumors
liberated into the synaptic cleft may diffuse out into the surrounding area,
and under certain circumstances, may be detected in CSF. It is apparent
that it is a long road from synaptic cleft to CSF and many problems arise
in interpreting such data. The most obvious of these is the lack of knowl-
edge as to the specific site of origin of the neurohumor detected. Other
questions to be raised pertain to the rates of appearance and disappearance
of these substances in CSF. Monamine oxidase activity' and acetylcholine-
sterase are both present in CSF, presumably capable of acting on appro-
priate substrates.* Nonenzymatic destruction may also occur.
The site of withdrawal of CSF is also an important factor to consider in
interpreting results. Many of the substances to be reviewed here have been
found in ventricular and cisternal fluid but not in lumbar CSF. Histamine
shows an opposite distribution as it is found in higher concentrations in
lumbar fluid.: The reason for these variations is not entirely clear but is
*It appears that levels of acetylcholine which are usually found in CSF are too
small to allow it to act as an effective substrate for acetylcholinesterase." The same
may be true of 5-hydroxytryptamine, since relatively large amounts of 5-HT are re-
quired to demonstrate monamine oxidase activity.' Thus the minute concentrations
of neurohumors in CSF may protect them from enzymatic destruction.
# Actually most substances in CSF (glucose is an exception) are present in higher
concentrations in a cranio-caudal direction.'1 For example, in central nervous system
syphilis, ventricular fluid may show a negative Wasserman reaction when cisternal
fluid will be weakly positive and lumbar fluid strongly positive.
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probably dependent on the site of origin of the substance in question and
the dynamics of CSF resorption.
In general, one might consider the study of CSF as complementary to
analysis of brain tissue and as particularly suitable in situations where di-
rect access to the brain is unobtainable.
"POSTERIOR PITUITARY-LIKE" SUBSTANCES (TABLE 1)
Prior to the extensive development of neurohumoral physiology, sub-
stances with oxytocic, pressor, antidiuretic and chromatophore-stimulating
properties had been described in CSF. Many of the first workers thought
these effects were due to posterior pituitary substance secreted into the
CSF via the third ventricle. For this historical reason, the studies on
'posterior pituitarylike' substances have been considered first in this re-
view.
Cushing and Goetsch" were the first modern workers to investigate the
biological properties of CSF. They reported in 1910 that CSF obtained
from human hydrocephalics caused a definite biphasic change in the blood
pressure of a rat, initiated peristalis in the rat, and caused dilatation of the
isolated frog's pupil. They speculated that these changes were due to pitui-
trin in the CSF occurring by virtue of the proximity of the third ventricle
to the posterior lobe of the pituitary gland. This observation was not fur-
ther pursued until the 1920's when other investigators began publishing
reports along similar lines. Dixon2' stated that the fluid obtained from the
subcerebellar cistern of dogs "show every known chemical and physiological
effect of pituitrin." Miura" and Trendelenburg9 demonstrated oxytocic and
melanophore-stimulating effects of CSF obtained from rabbits. Mestrezat
and van Caulaert' stated that the oxytocic action was present in CSF ob-
tained via cisternal puncture of dogs and humans with 'mental disease' but
not when obtained by lumbar puncture. Hoff and Wermer& claimed that the
oxytocic factor obtained from cisternal fluid of dogs, was much increased by
exposing the dogs to cats prior to withdrawal of fluid. Karplus and Pecze-
nik,40 in a series of carefully described experiments, reported that electrical
stimulation of the hypothalamus or tuber cinereum of the cat caused an oxy-
tocic substance to be released into CSF. Stimulation of the cervical sympa-
thetic nerves or nervus ischiadicus did not elicit this effect. In addition to the
oxytocic effect, a substance was also elicited that would darken the erythro-
phores of the minnow. They concluded that pituitrin and intermedin were
liberated into the CSF under the influence of hypothalamic activity. This
work may be considered as a forerunner of the present day intense interest
in hypothalamic-pituitary relationships.
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Van Dyke et al.7' criticized the methodology of some of the above-men-
tioned papers and stated, on the basis of their own experiments, that the
oxytocic effect of CSF was really due to its increased calcium concentra-
tion as compared to the usual perfusion fluids for guinea pig uterus. How-
ever, Cushing in his monograph Pituitary Body and Hypothalamus"' re-
viewed the extant literature and decided that Van Dyke's conclusions were
not valid. He states: "From the physiologic side . . . . the unmistakable
presence in the CSF of a substance, which if not the active principle (of
posterior pituitary) at least possesses similar properties, has since been
clearly demonstrated by a number of workers."
Further investigations yielded conflicting results. Simon' and Friedman
and Friedman, S using more refined techniques, were not able to confirm the
presence of pressor or oxytocic activity in cisternal fluid of dogs or in con-
centrated lumbar fluid of humans. Volhard"' studied 37 cisternal fluids from
patients attending his hypertension clinic. Six of the 37 caused a contrac-
tion of guinea pig small intestine, but Volhard did not feel this was due to
posterior pituitary substance. On the other hand, Barbour and Hambour-
ger' said an oxytocic effect could be produced by submitting cats to a hot
bath prior to cisternal taps while a cold bath would not accomplish the
same effect! I. H. Page" demonstrated the presence of a highly active
pressor substance in the fluid obtained post mortem from human cerebral
ventricles, a substance much more potent than any present in lumbar fluid.
Deleonardi" reported that the active substance obtained from cisternal fluid
of rabbits or dogs, and from ventricular fluid of humans, showed oxytocic,
antidiuretic, and pressor properties. Fluid obtained via lumbar puncture
did not have these properties.
A particularly ingenious series of experiments was reported by Ungar
in the years 1938-39.7`7' He claimed that the oxytocic effect of cisternal
fluid obtained from cats or dogs could be augmented or inhibited in several
ways. Stimulation of the superior cervical ganglion and the peripheral end
of the 2nd posterior spinal root caused a marked increase of the oxytocic
effect, while stimulation of the cervical chain or the 3rd posterior spinal
root produced no change.7' Ungar related this to the pattern of autonomic
innervation of the pituitary. Other devices for augmenting the oxytocic
effect were shining a bright light into a cat's eye and direct stimulation of
the optic nerve.7'
Since 1940 there seems to have been little interest in further investiga-
tions of these phenomena. Van Dyke has never accepted the idea that
posterior pituitary substances can be found in CSF."'7' Recently, Scavo"
reviewed the literature dealing with antidiuretic hormone in body fluids and
18
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concluded that the question of the presence of ADH in CSF is still un-
settled.
In attempting to critically assess this array of contradictory reports that
are usually not comparable, one is left with the feeling that pharmacologic-
ally active substances can be induced to appear in CSF by virtue of various
stimulatory techniques. CSF obtained from ventricular or cisternal areas
have higher concentrations of these substances than that obtained from
lumbar sites. It seems impossible that all these effects could be due to arti-
facts in the experiments (e.g. high calcium content of perfusion fluid).
However, it is entirely unclear as to whether these substances are related
TABLE 2. SOME PHARMACOLOGICAL EFFECTS OF NEUROHUMORS
Oxytocic Pressor Antidiuretic
Acetylcholine pos pos
5-hydroxytryptamine pos pos
Histamine pos
Noradrenaline pos
in any way to the polypeptide hormones of the neurohypophysis. The activ-
ity of the neurohumors to be discussed subsequently may have substantially
contributed to these findings as they were only beginning to be appreciated
at the time most of this work was done. Acetylcholine antagonists, such
as atropine, were usually not added to perfusion fluids although Unga'
briefly mentions that his effects were not abolished by atropine. He also
states that his contractions were more persistent than those induced by
either histamine or acetylcholine, but supplies no details upon which to
evaluate his statements.'
Some pharmacological properties of the cerebral neurohumors are listed
in Table 2 to illustrate how their presence could easily simulate posterior
pituitary substances in CSF. Only the chromatophore-darkening effects
cannot be explained in this way since neurohumors actually tend to oppose
melanin stimulating hormone (lightening effect.)" However, adrenocorti-
cotrophic hormone, which has also been reported in CSF (see below), has
darkening activity similar to MSH. In general, one might suspect that
many of the effects described above were due to neurohumoral substances
in the CSF, but only further studies, utilizing our present knowledge of
the properties of neurohumors, can satisfactorily resolve this problem.
20
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ANTERIOR PITUITARY HORMONES
There are a few reports on the presence of anterior pituitary hormones
in CSF. Van Bogaert and van Baarle76 described a corticotrophic effect of
CSF obtained from hypertensive dogs and humans. Lachnit and Weis'
claimed that ACTH activity, as determined by ascorbic acid depletion in rats'
adrenals, can be demonstrated in the CSF of patients with 'pituitary baso-
philism', while patients with primary adrenal disease did not show this
phenomenon. They utilized this technique as an aid in differential diagno-
sis of these two conditions. Similarly, Soucek' reported that 3 out of 4
cases with Cushing's disease due to pituitary tumors had CSF that gave
positive Aschheim-Zondek reactions. This was interpreted as indicating
the presence of gonadotrophic hormone in CSF.
ACETYLCHOLINE (ACH) (TABLE 3)
Feldberg and Schriever" demonstrated in 1936, that the intravenous in-
jection of eserine caused Ach to appear in the CSF obtained from the basal
cisterns of dogs. Adrenaline and asphyxia increased the amount of Ach in
CSF of these eserinized animals. These findings were subsequently con-
firmed by other investigators under various conditions. Chang et aU.' stated
that stimulation of the central end of the cut vagus nerve would cause in-
creased Ach to appear in the CSF of eserinized animals. Adam et al.' de-
scribed the same finding upon stimulation of the central end of several peri-
pheral nerves. They also mention that while stimulation of the motor and
cerebellar cortex is without effect, stimulation of the hypothalamus pro-
duced doubling of the Ach levels in 7 out of 14 animals studied. It is of some
interest, in view of the reports summarized in the first section of this paper,
that the authors state that perfusion of the ventricular system with pituitrin
(10 units/cc) caused doubling of the Ach concentration, while perfusion
with adrenaline had no effect.
Bornsteine0 in 1946 published a widely-quoted report on the presence and
effect of Ach in CSF of cats subjected to experimental head trauma. He
showed that Ach consistently appeared in CSF obtained by cisternal punc-
ture of these animals in concentrations of 0.027-0.090 ,gm/cc. The Ach
could be demonstrated up to 48 hours after the trauma and then disap-
peared. The animals themselves initially showed tonic-clonic seizures,
apnea, loss of placing reactions and finally stupor. Electroencephalograms
revealed paroxysmal high-amplitude bursts of activity at first and then
diminished activity with stupor. Bornstein stated that the EEG patterns
and stuporous condition could be reversed by administration of atropine
in doses of 0.5-1.0 mgm/kg although loss of placing reactions remained.
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He also claimed that administration of intracisternal Ach duplicated both
the behavioral and EEG picture of traumatized animals and could be sup-
pressed with atropine. On the basis of this study, Ward'8 and later Jenk-
ner88, 9 gave anticholinergic drugs to patients with closed craniocerebral
trauma and reported striking results in some instances, particularly with
Jenkner's use of the centrally-acting phenothiazine 'diparcol.'
Frequent surveys have been conducted on patients with neurologic and
psychiatric disorders for the purpose of searching for Ach in the CSF.
Bioassay preparations used include the dorsal muscle of the leech,24'""' the
frog lung"12' the frog abdominal rectus muscle,"'" and most recently, the
heart of the mollusc Mercenaria (Venus) mercenaria."'
5 7W.'W,67 '0 These
methods are all characterized by a considerable degree of sensitivity to Ach
as concentrations reported are rarely higher than 0.1 ,ugm/cc. The frog
lung is the most sensitive of these test organs, being able to detect Ach at
a concentration of 10-' gm/cc!
Earlier investigators found Ach in a wide variety of disease states-psy-
choses, general paresis, alcoholic polyneuritis and seizure states.2'1' 24 6"
Brecht and Kummer" reported that Ach present in CSF of psychotic pa-
tients was not increased by electroshock therapy. Stiittgen and Jacob'
studied CSF from 72 various sources and found an 'Ach-like' substance
frequently. They state that a short period of heating at an acid pH in-
creases the level of biologically active substances detectable in CSF.
Tower,"s in one of the most extensive and carefully studied series, has
stated that Ach is not present in normal CSF but is present in epilepsy up
to 0.050 pgm/cc (average 0.010 ,ugm/cc) and following craniocerebral
trauma up to 1.0 ,gm/cc in severely involved patients. He found no asso-
ciation between the type of epilepsy and the amount of Ach present. Pa-
tients with positive CSF tended to have more extensive EEG changes and
increased frequency of seizures. All specimens obtained during ictal and
immediate postictal periods were positive for Ach. Many of the interictal
specimens, however, were also positive. Anticonvulsant medication did not
seem to affect the presence of Ach.
Poloni5 in 1951 published a remarkable report regarding the absence
of Ach in the CSF of schizophrenic patients. He studied the CSF of 110
patients with neuropsychiatric disorders and 10 normal individuals. He
reported that the 10 normals and almost all of the patients except the
schizophrenics, had Ach levels in their CSF ranging from 0.0001 to 0.1
,gm/cc. Forty-eight out of the 50 schizophrenics, however, had no detect-
able Ach in their spinal fluid. Other patients included "hysterics, epilep-
tics, depressives, manics, senile dementia, alcoholics, and post-encephali-
22
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tics." At the same time, he describes a 'curare-like' substance present only
in the CSF of schizophrenics and paretics, which had the effect of relaxing
the leech muscle utilized for the assay. This substance antagonized Ach-
induced contractions of the muscle but did not affect potassium-induced
contractions. It was highly stable as opposed to Ach which required Tow-
er's method of preservation in CSF (neostigmine plus acidification of
CSF).' Manipulations that should have destroyed Ach did not affect this
substance which Poloni measured as equivalent to 1.0-10.0 ,ugm/cc of d-tu-
bocurarine. Recently, Turner and Mauss' published a report studying
CSF from similar categories of patients which they interpret as not sup-
porting Poloni's findings. They found ACh in amounts under 0.020 ,ugm/cc
in roughly one-half of 59 fluids studied, but found no correlation between
the presence of Ach and diagnostic groups. Ach was said to be found in
schizophrenics in roughly the same frequency as other patients. This study
cannot be interpreted as conclusively disproving Poloni's findings since only
11 lumbar fluids from schizophrenics were analyzed, yielding 4 samples
positive for Ach. Poloni's report of curare-like activity in CSF was not
investigated by these authors.
Kunkle' has reported Ach in CSF of 5 out of 9 patients with migraine
headaches while no Ach was found in 35 of 37 patients without migraine.
The two patients of this latter group who were free of migraine but did
have Ach in their CSF were subject to grand mal seizures.
Bhattacharya, Feldberg, and Vogt7 have further complicated matters by
reporting a substance in human CSF that sensitizes frog rectus muscle to
Ach which is demonstrated when the Ach is added subsequently. They feel
that this agent may be a lipoprotein normally present in CSF. A similar
phenomenon utilizing the clam heart as a test object has been noted.'9
In reviewing these diverse reports of Ach in CSF, the same problems
of comparability arise as with posterior pituitary-like substances. A few
generalizations, however, can be formulated. Experimental electrical or
chemical stimulation of the CNS in an appropriate manner, as reviewed
above, will cause Ach to appear in the CSF of eserinized animals. Con-
centrations of Ach can be frequently found in CSF in many disease states,
and may even be normally present in human CSF. The problem of decid-
ing upon a normal range, and making valid clinical correlations with ele-
vations above this, is almost impossible at this time. A rough approxima-
tion might indicate 0.001 jugm/cc as a dividing line under which investiga-
tors have frequently found Ach in CSF. Levels of 0.01 to 1.0 ,ugm/cc have
usually been only found in certain neurological disorders, which at this time
24
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include seizure disorders, craniocerebral trauma, and possibly migraine
headaches.
Poloni's report of a curare-like substance associated with the absence of
Ach in the CSF of 48 out of 50 schizophrenics seems particularly surpris-
ing in view of the current trend of thought that schizophrenia is a disease
of multiple etiology. Although none of the other studies reviewed here in-
dicated such an association, Poloni's claim has never been specifically dis-
proved in the literature.
HISTAMINE
The first reported study of histamine in CSF was by Zadina and Petran'
in 1938. They mention finding "very small amounts of histamine" in CSF
of most patients studied and increased amounts in two cases of schizo-
phrenia. Trabucchi'6 measured histamine in the CSF of 20 normal and
schizophrenic patients. He stated that histamine was never present in con-
centrations over 0.01 ugm/cc in any of the cases and could not relate the
height of the levels to the diagnosis.
In 1949, three different papers appeared almost simultaneously reporting
data on determinations of histamine in CSF and reviewing the literature up
to that time. Autio and Ermala,3 using the guinea pig duodenum as their
test object, found average levels of 0.043 ygm/cc in CSF of neuropsychiatric
patients obtained by cisternal puncture, and 0.091 when obtained by lum-
bar puncture. This is an interesting finding in view of subsequent reports
of unusually high histamine concentrations in dorsal root ganglia. They
found that extraction of histamine with a conventional trichloracetic acid
technique yielded higher values than when CSF was directly added to the
test organ. Jackson and Rose,37 using a similar method, report much lower
levels in CSF, averaging 0.01 ,ugm/cc with a range of 0.002 to 0.03 ugm/cc.
The highest level was found in a case of trigeminal neuralgia. No associa-
tions were made, other than that patients with high CSF cell counts tended
to have higher histamine levels. Corrado"8 as well as Stiittgen and Jacob,'
utilizing raw CSF on guinea pig ileum, reported average levels of 0.025
,ugm/cc and 0.045 ,ugm/cc, respectively. None of these authors could sig-
nificantly relate the histamine levels to the presence of psychiatric or neuro-
logical disorders.
Baccarini and Volpicelli' have further indicated the association of CSF
histamine with the cellular elements in CSF by reporting, in a small group
of cases (seven), that the sediment of centrifuged CSF generally contained
most of the measurable histamine.
25YALE JOURNAL OF BIOLOGY AND MEDICINE Vlm 3 uut16
Many of the recent studies of histamine in CSF have the virtue of utiliz-
ing methods which involve specific extraction of histamine prior to bio-
assay,"'7 rather than the use of raw CSF as has often been used in studies
of other pharmacologically active substances. Even so, the average levels
reported vary considerably among different investigators (0.01 to 0.09
t&gm/cc). Histamine seems to be constantly present in CSF, but all work-
ers since Zadina and Petran agree that the levels are not related to the
presence of neuropsychiatric disease.
CATECHOLAMINES (ADRENALINE AND NORADRENALINE)
Only two reports have been found describing catecholamines in CSF.
Although these utilized chemical rather than biological methods, they have
TABLE 4. CSF LEVELS OF CATECHOLAMINES (WEIL-MALHERBE)
Organic brain lesions Chronic schizophrenia
Adrenaline 0.9 4gm/liter 0.93 ggm/liter
Noradrenaline 2.46 "3.13 "I
been included here because catecholamines are usually listed in classifica-
tions of neurohumoral agents and have a high degree of pharmacological
activity. Weil-Malherbe and Liddell,' using the ethylene diamine conden-
sation method, reported adrenaline and noradrenaline levels in the CSF
of patients with organic brain lesions and with schizophrenia (Table 4).
The levels generally are proportional to, although less than, those found
in plasma using the same method. Manger et al.'7 usilng a modification of
the Weil-Malherbe method, subsequently reported that total epinephrine-
like substances in CSF average 0.8-1.2 p&gm/liter.
The methodology of catecholamine determinations, utilizing colorimetric
or fluorimetric techniques, is at present quite controversial; hence, meas-
urements of the small concentrations found in CSF must be regarded with
considerable caution. However, in view of the sensitivity of the 'reticular
activating system' to adrenaline,''' this area has much promise if appro-
priate assay techniques can be developed.
5-HYDROXYTRYPTAMINE (5-HT, SEROTONIN)
Reports of 5-HT in CSF are of quite recent origin. In 1957 Sachs'
first reported this substance to be present in CSF of patients following
craniocerebral trauma. He utilized as his test object, the clam heart (Venus
26
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mercenaria), a preparation that is particularly useful in surveys of CSF
because it is highly sensitive to both 5-HT and Ach. 5-HT produces in-
creased contractility of the heart while Ach produces the opposite effect.
Positive identification of these substances is usually felt to be reasonably
acceptable with the use of specific antagonists such as lysergic acid diethyla-
mide (LSD) for 5-HT and benzoquinonium ('Mytolon') for Ach. Sachs
found 5-HT as well as Ach in a number of the patients he investigated, thus
enlarging upon Tower's earlier reports that Ach appears in the CSF of
patients undergoing head trauma.
Bogdanski, Weissbach, and Udenfriend,8 as part of their pharmacological
analysis of 5-hydroxytryptophan, reported that 5-HT appears in the CSF
of cats and dogs up to levels of 0.14 ugm/cc following administration of
TABLE 5-DATA FROM TURNER AND MAUSS
Ach 5-HT
Totalno. No. of Av. level No. of Av. level
Origin of CSF offluids positives ,.tgm/cc positives ,gm/cc
Ventricular 15 11 0.006 8 0.012
Lumbar 44 20 0.0056 9 0.006
5-HTP (a precursor of 5-HT). The authors have shown that brain 5-HT
increases up to tenfold, and is associated with marked behavioral and auto-
nomic changes which they interpret as resembling an LSD effect. The sig-
nificance of these findings awaits an understanding of the role played by
5-HT in the brain.
Feldtman, Izak, and Nelkeni could not find significant amounts of 5-HT
in CSF of patients with multiple sclerosis and other neurological disorders.
Turner and Mauss' have reported an extensive series of cases, as men-
tioned in the Ach section, utilizing the clam heart in the same way as Sachs
did. They studied raw spinal and ventricular fluids from subjects with
schizophrenia and a variety of neurological conditions (see Table 5). 5-HT
was found in about one-third of all fluids studied. No significant correla-
tions could be made between the levels found and the diagnostic groups
studied. It appears that there is a tendency for ventricular fluids to have
higher 5-HT levels, although the authors did not feel that this was a sig-
nificant difference.
Freedman, Giarman, and Picard-Ami,' testing a 95%o acetone extract
of CSF on the clam heart, have been able to detect on only rare occasions
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minute amounts of 5-HT (under 0.01 pgm/cc) in the CSF of schizophrenic
patients. Schain studied a group of 30 specimens of raw lumbar CSF from
subjects with various neuropsychiatric disorders, using the clam heart and
the rat uterus in estrus. 5-HT could be definitely identified on only one
occasion (infantile autism). It has been noted that most CSF stabilizes
and increases the height of the base-line contraction of the heart. Subse-
quent to this effect, many hearts become more sensitive to additions of the
standard solution of 5-HT. These phenomena may often hinder the assay-
ist from accurately assessing the presence and level of 5-HT in CSF.
The levels of 5-HT in CSF reported by Turner and Mauss tend to ap-
proach the lower limits of sensitivity of the clam heart to 5-HT by the
usual assay methods. Some doubt must be expressed as to whether levels
under .005-.01 ,ugm/cc can be accurately identified as 5-HT. Furthermore,
data obtained by techniques utilizing relatively purified extracts of 5-HT,
may be looked upon with considerably more confidence than those derived
from raw body fluids. This problem of the use of raw fluids in bioassay
procedures will be discussed again below.
POLYPEPTIDES
Chapman and Wolff` have reported the presence of a proteolytic en-
zyme in the CSF of patients with active inflammatory or degenerative cen-
tral nervous system disease, migraine headaches, prolonged pain, and
chronic schizophrenia. This protease is identified by virtue of its capacity
to form what appears to be a biologically-active polypeptide (bradykinin)
when CSF is incubated with a globulin-containing solution. The polypep-
tide is assayed on rat uterus or guinea pig ileum. Sometimes the CSF
seems to contain the polypeptide even without incubation with globulin
which the authors attribute to the action of the protease on CSF globulins
in 7nvo.
Many biologically active polypeptides have been detected in body fluids
and tissues, and have been the subject of much investigation.' One of them,
Substance P, is found in appreciable amounts in the brain and has been
considered as a possible neurohumoral transmitter. Posterior pituitary sub-
stance mentioned previously as frequently reported in CSF, is now known
to be a mixture of several polypeptides with different pharmacological
effects that are found in the neurosecretory elements of the hypothalamus
and the hypothalamic-hypophysed tract. The possible relationship of local
neurosecretion to brain function is of much interest but beyond the scope
of this review.
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DISCUSSION
The chaotic mass of data reviewed above does not lend itself readily to
critical analysis. Furthermore, the fact that there is no real understanding
of the normal role played by neurohumors in the CNS complicates the prob-
lem still more. Nevertheless, the author feels that investigating the pat-
terns of neurohumors in CSF offers a parameter for study that may directly
reflect the dynamics of brain function, and should be pursued in spite of
the lack of clarity of the field.
The data reviewed on 'posterior pituitary-like' substances in CSF
clearly indicate that an agent (or agents) with diverse pharmacological
effects appears in increasing concentration in CSF when certain CNS stim-
uli are applied. Reinvestigation of this problem should be attempted in
light of our extensive knowledge of the properties of neurohumors as well
as polypeptide hormones.
The presence of measurable Ach in CSF has been clearly established in
many experimental and clinical situations, although the levels found vary
greatly. The association of increased Ach levels with craniocerebral trauma
and epilepsy seems definite. It has been felt that this represents a massive
release of Ach from neurons secondary to trauma or seizure activity. This
is certainly true of trauma, but one might speculate whether epileptics are
frequently releasing excessive amounts of Ach that is a sign of their pre-
disposition to seizures. The fact that elevated Ach levels have been found
in the CSF of epileptics during interictal periods' would support such a
hypothesis. There is some evidence that convulsions produced by electro-
shock therapy do not produce Ach elevations as readily as naturally oc-
curring seizures do."' The data on choline acetylase activity in epilepto-
genic cortex has been contradictory,' but the increasing emphasis at pres-
ent on techniques of studying particulate (bound) versus free Ach in the
brain' might help resolve this problem. Perhaps Ach in CSF reflects con-
vulsive threshold as well as convulsive activity.
Bornstein'0 and Feldberg and Sherwood'7 have shown that cisternal or
intraventricular administration of Ach to cats produces, among other effects,
a dazed or stuporous reaction. One wonders whether some of the sympto-
matology of the postictal state is due to Ach in CSF.
The biogenic amines have been intensively investigated for the past
decade, particularly with respect to their possible relationship to mental
illness. There has been no evidence presented to indicate that abnormal
CSF (or brain) levels are present in mental or nervous disease. It may
be that these substances are not normally released into the synaptic cleft,
as Ach probably is, and are therefore less likely to diffuse out into CSF.
29
I SCHAINYALE JOURNAL OF BIOLOGY AND MEDICINE
Catecholamines in CSF undoubtedly reflect plasma levels of these sub-
stances. 5-HT in blood is almost entirely bound to platelets, and it is not
surprising that 5-HT is not as readily detectable in CSF as are catechola-
mines. Where 5-HT is found, it would be worthwhile to study the sedi-
ment of centrifuged CSF to see if the cellular elements are the source of
5-HT, as seems to be often true of histamine.'
A few other suggestions regarding further investigations of this type may
be made. Although the surveys of heterogeneous patient groups described
above are initially necessary, continued advances will now probably come
as the result of sustained studies of specific pathological states where prom-
ising leads have been found. One such area is the association of Ach in
CSF with convulsive disorders. The study of psychomotor seizure states
might be a particularly fruitful type of fit to study in view of the high levels
of neurohumors found in certain regions of the 'limbic system."' If 5-HT
from neural sources were ever to make its appearance in CSF, one might
think this should occur during a psychomotor seizure originating from an
area rich in 5-HT. It would be of interest to correlate CSF findings with
EEG studies in the so-called 'epileptic equivalent' states, e. g. abdominal
pain, headaches, nightmares, etc., that are thought to be at times the mani-
festations of seizure disorders. Identification of these symptoms as epilep-
tic equivalents is often quite difficult, and evidence of abnormal Ach or other
neurohumoral levels in CSF would be of much interest.
Poloni's provocative report has not been mentioned again in the litera-
ture, except by Turner and Mauss, as far as the writer has been able to
determine. His findings should be either confirmed or disproved, for if
true, they would have major implications regarding a neurohumoral
abnormality in schizophrenia.*
The study of neurohumors in CSF in association with the administration
of drugs is a second approach that might provide pertinent information
regarding the mechanism of action of neurotropic drugs. Evidence is accu-
mulating that these preparations exert their effect by acting on neurohu-
moral mechanisms. It would seem reasonable that administration of such
drugs might be associated with the appearance of neurohumors in the CSF
or with changes of levels already present. The observation of Bogdanski
et al.,8 as mentioned above, is an example of evidence that administration of
a precursor of 5-HT causes the latter to appear in CSF with the simul-
* Poloni has described other pharmacologically active substances in CSF. He char-
acterizes CSF from epileptics as having 'antidiuretic, adrenocorticotrophic and epi-
leptogenic' properties. CSF from schizophrenics has 'anti-epileptogenic, diuretic and
curare-like' properties. This work is summarized in Poloni, A., Riv. neurol., 1954,
24, 863.
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taneous development of marked behavioral changes. A well-known older
observation is the fact that administration of an anticholinesterase such as
eserine, causes Ach to appear in the CSF.78" Possibly other enzymatic in-
hibitors such as monamine oxidase inhibitors, would cause other neuro-
humors to appear in CSF in an analogous fashion. Drugs such as reserpine
that are thought to decrease the binding capacity of subcellular particles for
amines, might produce similar effects. Speculations of this sort could be
easily tested by the analysis of CSF in drug-treated animals.*
Cisternal CSF should be obtained more often, rather than relying ex-
clusively on lumbar CSF, since the former may yield positive data where
lumbar fluids are negative. Unfortunately, cisternal puncture is rarely
attempted in this country or is generally regarded as a dangerous pro-
cedure. Actually, this technique is widely used in continental Europe and
Schonenberg states that suboccipital (cisternal) puncture is the procedure
of choice for obtaining CSF in all but young children or infants.' He re-
views the literature and concludes that, while unfortunate sequelae have
been reported, they are extremely rare.
A final point that should be emphasized is the necessity for rigorous
technique in the use of bioassay procedures. Much of the difficulty with
these techniques is due to inadequate separation (or no separation at all)
of contaminating tissue factors from the substance to be measured. It is
well-known that tissue extracts commonly exert sensitizing effects on bio-
logical preparations,"'" and it has been observed above that an unknown
substance in CSF will sensitize the response of test organs to Ach and
5-HT. The use of specific pharmacological antagonists for identification
is only a partial answer as the antagonists themselves may exert prolonged
effects on the test object and will slow down an already time-consuming
procedure. Increased emphasis on extraction methods would do much to
improve the reproducibility of bioassay results.
Regarding the test object itself, the same biological preparation will vary
considerably over a period of time in its sensitivity to active substances.
The usual bioassay method requires the bracketing of the unknown between
two standards that demonstrate clearcut dose differentiation.* Preliminary
'testing of the sensitivity' without continual use of the standard solution is
* Bhattacharya and Feldberg's technique of slowly perfusing the ventricular system
of cats and collecting the effluent from the cisterna magna or aquaduct,' might pro-
vide a continual source of CSF useful for investigating the influence of neurotropic
drugs in releasing pharmacologically active substances into CSF.
* Other, more refined, techniques are also available if greater degrees of accuracy
are required, such as in determining drug potency (Burn, J. H., Finney, D. J., and
Goodwin, L. G.: Biological standardization, 2d ed. London, Oxford University Press,
1950).
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a quite unreliable procedure, particularly when using a raw body fluid such
as CSF. The significance of the data obtained from bioassay techniques, as
in any other laboratory procedures, is directly related to the care taken
in attempting to obtain quantitative analysis.
SUMMARY
1. The literature dealing with pharmacologically active substances in
CSF has been reviewed. Many earlier reports described oxytocic, pressor,
antidiuretic and chromatophore-stimulating agents in CSF. These cannot
be considered as all artifacts, but the identity of the active principles has not
been determined.
2. Acetylcholine is the only pharmacologically active substance of clearly
neural origin, that has been specifically identified in CSF. Craniocerebral
trauma and seizure states are associated with higher levels of acetylcholine
in CSF.
3. Histamine, catecholamines and 5-hydroxytryptamine have all been
reported in CSF, but it cannot be assumed that these substances in CSF
originate from neural tissue.
4. Certain suggestions for further research have been discussed. These
primarily deal with the study of CSF neurohumors in seizure disorders,
and following the administration of neurotropic drugs.
5. Bioassay methodology has been discussed. Much stress has been
placed on the importance of using extraction methods prior to assay. The
principles and some pitfalls of bioassay technique have been briefly men-
tioned.
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